HomeGeneticsConditionFuchs endothelial dystrophy
Back to Condition
Fuchs endothelial dystrophy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Fuchs endothelial dystrophy

Fuchs endothelial dystrophy is a condition affecting the cornea that leads to blurred vision, sensitivity to light, and potential eye pain.

Overview

Fuchs endothelial dystrophy affects the front surface of the eye, known as the cornea. The first symptom is typically blurred vision in the morning that clears during the day. Over time, individuals lose visual acuity and become sensitive to bright lights.

During an eye exam, deposits called guttae are detectable in the middle of the cornea. These eventually spread, contributing to cell death and corneal swelling. Tiny blisters may develop on the cornea, which can burst and cause eye pain. Symptoms usually begin in a person's forties or fifties, though a rare early-onset variant can affect vision in a person's twenties.

Frequency

The late-onset form affects approximately 4 percent of people over age 40 in the United States. The condition affects women two to four times more frequently than men.

Causes

Fuchs endothelial dystrophy involves the death of corneal endothelial cells, which line the back of the cornea and regulate fluid balance. When these cells die, the cornea becomes swollen with fluid, leading to vision problems.

While the genetics are complex, researchers have identified several genes that may play a role:

  • COL8A2: Mutations in this gene cause some cases of the early-onset variant. This gene provides instructions for a protein that is part of type VIII collagen, a major component of Descemet's membrane, which supports corneal endothelial cells.
  • TCF4, AGBL1, ATP1B1, KANK4, LAMC1, SLC4A11, and ZEB1: These genes are also associated with the condition.

Inheritance

The inheritance pattern is often unknown. In some families, it follows an autosomal dominant pattern, where one copy of the altered gene is sufficient to cause the disorder. Some cases result from new mutations in a gene and occur in people with no family history of the disorder.

Frequently Asked Questions

Topical hypertonic saline (5% NaCl) drops or ointment can temporarily draw fluid out of the cornea and improve vision. Maintaining good ocular surface health with lubricants, avoiding prolonged contact‑lens wear, and protecting the eyes from trauma or inflammation may help preserve remaining endothelial cells, but no medication has been proven to halt cell loss.
Surgery is considered when visual acuity drops below 20/40 despite optimal medical therapy, or when painful epithelial bullae develop. Most surgeons now favor endothelial‑only procedures such as Descemet membrane endothelial keratoplasty (DMEK) or Descemet stripping automated endothelial keratoplasty (DSAEK) because they restore vision faster and have lower rejection rates than full‑thickness grafts.
Morning blur that clears as the cornea “dries out” is classic for early Fuchs because fluid accumulates overnight when eyelids are closed; normal dry‑eye blur usually improves with artificial tears and does not follow this pattern.
genetic component exists—mutations in several genes (e.g., COL8A2, TCF4) are linked to the disease—but most cases are sporadic. First‑degree relatives with symptoms should have a comprehensive eye exam, including specular microscopy, to detect early endothelial changes.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA